Role of opioid antagonists in the rat liver ischemia model.
Naujokat
P
P
Department of Research, Borgess Medical Center, Kalamazoo, Michigan 49001.
Xavier
R
R
Lopez
J
J
Walters
W
W
Toledo-Pereyra
L H
LH
D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D006499:Hepatic Artery / Q000502:physiology; D007511:Ischemia / Q000473:pathology / Q000517:prevention & control*; D008099:Liver / Q000098:blood supply* / Q000187:drug effects / Q000473:pathology; D009266:Nalbuphine / Q000627:therapeutic use; D009270:Naloxone / Q000627:therapeutic use; D009271:Naltrexone / Q000031:analogs & derivatives / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D011169:Portal Vein / Q000502:physiology; D051381:Rats; D011919:Rats, Inbred Strains; D014700:Verapamil / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D009292:Narcotic Antagonists; D009270:Naloxone; D009271:Naltrexone; D014700:Verapamil; D009266:Nalbuphine; C038981:nalmefene